Beximco Pharmaceuticals PLC - Bangladesh-based medicine manufacturer - Partners with vaccine producer Serum Institute of India Pvt Ltd on cooperation and distribution agreement to develop Covid-19 vaccine, for which Beximco will be the exclusive supplier in Bangladesh. Serum has partnered with AsstraZeneca PLC, Gates Foundation and Gavi to producer more than billion doses of a vaccine for global supply.
Current stock price: 60.25 pence
Year-to-date change: up 31%
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.